Member Sign In
Member Sign Out
Cancer & Disease Research
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
Senescent neuron discovery in brains opens path for Alzheimer's drug development
Scientists at the Salk Institute for Biological Studies have found that neurons from people with Alzheimer's disease show deterioration and undergo a late-life stress process called cellular senescence, while senescent cells could be a way to slow neuroinflammation and neurodegeneration.
Blocking cell plasticity is essential to tackling glioblastomas: review
Therapeutics that restrain the plasticity of glioblastoma are essential to improving outcomes in patients with the lethal, hard-to-treat brain cancer, according to researchers at Australia's Flinders University.
CRISPR-Cas9 gene editing links RNA-binding protein to immunotherapy resistance
Using CRISPR-Cas9 gene editing, Swiss researchers have provided evidence that expression of an RNA-binding protein helps tumors to evade the immune system.
Cell-penetrating peptide conjugate gets chemotherapy across blood-brain barrier in mice
A macrocyclic cell-penetrating peptide conjugate has enabled a cisplatin prodrug to cross the blood-brain barrier (BBB) in mice, increasing survival rates and providing a potential pathway for treating humans with brain cancer.
Immunosuppressive pathway offers explanation for failure of TIGIT clinical trials
Albert Einstein College of Medicine scientists in a new analysis of the immunosuppressive KIR2DL5/PVR pathway provide a potential explanation for why anti-TIGIT therapies have failed in clinical trials.
Maps of genetic subclones in tumors point to new way to treat cancers
Researchers have combined whole-genome sequencing with other techniques to generate detailed quantitative maps of genetic subclones in tumors, which they contend provide a complete view of cancer that has not been previously possible.
DNA barcoding shows how breast cancer cells evade the immune system
Using DNA barcodes, scientists at Australia’s Garvan Institute of Medical Research have revealed how cancer cells can evade the immune system and render immunotherapies ineffective.
Study offers researchers more reliable way to design effective CELMoD drugs
Scripps Research scientists have discovered a key property needed for a promising new class of cancer-fighting drugs -- known as Cereblon E3 Ligase Modulating Drugs (CELMoDs) -- to work effectively as protein degraders.
DNA-based ‘nanotransporters’ deliver precise concentrations of drugs
Canadian researchers have designed and validated a new class of DNA-based drug transporters that are 20,000 times smaller than a human hair, which they contend may improve how cancers and other diseases are treated.
Study provides path for overcoming blood-tumor barrier in treating medulloblastoma
Scientists at Toronto's Hospital for Sick Children have identified a way to reduce the impact of the blood-tumor barrier for treating medulloblastoma, the most common malignant pediatric brain tumor.
Cell Bio 2022
District of Columbia United States
Glasgow International Health Festival
January 25-26, 2023
More Conferences »»
NIH awards $3M grant to investigate Candida auris fungus treatment
Scientists uncover DNA repair mechanism, potential cancer target
Gene mutation may explain Alzheimer's brain plaque buildup
Scientists highlight new insights into triple-negative breast cancer
Increasing immune cell production may reverse cognitive decline: study
More articles »
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard